Company intelligence / Profile preview

Hikal

Mumbai, Maharashtra, Indiahikal.com ↗

Ownership: Private
Employees: ~3000
Development stage: Other

Overview

Hikal does not run its own clinical trials but manufactures active pharmaceutical ingredients and intermediates for global pharma companies. It provides contract research, development, and manufacturing services from early-stage to commercial supply. Its facilities meet stringent regulatory standards including US FDA approval. No proprietary clinical results reported.

Therapeutic areas: Infectious DiseasesNeurologyCardiovascularEndocrinology
Modalities: Small moleculeChemical synthesis products (for APIs, intermediates)
Industry: Contract Manufacturing Organization

Partnerships

Major partnerships with leading global pharmaceutical, biotech, animal health, crop protection, and specialty chemicals companies.

Beyond the preview

Go deeper on Hikal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hikal.

Explore the full profile